These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 3079080)

  • 1. Randomized clinical trial of cyclosporine or donor specific transfusions in high risk living-related donor transplantation.
    Bordes-Aznar J; Odor A; Dib-Kuri A; Gabilondo F; Kasep J; Peña JC; Herrera-Acosta J; Chávez-Peón F
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2276-7. PubMed ID: 3079080
    [No Abstract]   [Full Text] [Related]  

  • 2. Uselessness of donor-specific transfusions or prophylactic ALG with therapeutic cyclosporine doses in living related renal transplantation between one-haplotype matched pairs.
    Yamauchi J; Akiyama N; Sugimoto H; Tomikawa S; Mita K; Bekku Y; Ogawa Y; Imai T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1663-6. PubMed ID: 2652545
    [No Abstract]   [Full Text] [Related]  

  • 3. Donor specific blood transfusions do not improve graft survival in living related donor transplantation.
    Garcia VD; Kraemer ES; Prompt CA; Santos A; Caovila J; Duarte A; Filho AN; Goldani JC
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2271-3. PubMed ID: 3274507
    [No Abstract]   [Full Text] [Related]  

  • 4. Renal retransplantation from living related donors using donor specific blood transfusions.
    Shapira Z; Yussim A; Shmueli D; Mahinson A; Reichenthal E; Servadio C
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2280-1. PubMed ID: 3274508
    [No Abstract]   [Full Text] [Related]  

  • 5. Donor-specific transfusion for kidney transplantation in the cyclosporine era.
    Inoue S; Aikawa M; Dobashi Y; Kuzuhara K; Yanagisawa T; Ootubo O; Mimura N
    Transplant Proc; 1996 Jun; 28(3):1220-1. PubMed ID: 8658633
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative study of two protocols for living-related renal transplantation: donor-specific transfusion versus cyclosporine.
    Mazzali M; Alves Filho G; Alves MA; de Faria JB
    Transplant Proc; 1995 Apr; 27(2):1832-3. PubMed ID: 7725525
    [No Abstract]   [Full Text] [Related]  

  • 7. Enhancement of renal allografts by simultaneous cyclosporine and donor-specific blood transfusion.
    Francis DM; Masendycz PJ; Dumble LJ; Clunie GJ
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1464-6. PubMed ID: 3274356
    [No Abstract]   [Full Text] [Related]  

  • 8. Three year experience of donor specific transfusion and concomitant cyclosporine A.
    Hillis AN; Duguid J; Evans CM; Bone JM; Sells RA
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2248-9. PubMed ID: 2978890
    [No Abstract]   [Full Text] [Related]  

  • 9. Single pretransplant donor-specific transfusion in cadaver and living related donor renal transplantation.
    Alexander JW; Davies CB; First MR; Cofer BR; Munda R; Madden RL; Hariharan S; Schroeder TJ
    Transplant Proc; 1993 Feb; 25(1 Pt 1):485-7. PubMed ID: 8438389
    [No Abstract]   [Full Text] [Related]  

  • 10. The transfusion effect.
    Tokunaga K; Terasaki PI
    Clin Transpl; 1986; ():175-88. PubMed ID: 3154399
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stored-blood donor-specific transfusions with cyclosporine in distantly related and unrelated donor-recipient pairs.
    Hefty TR; Barry JM
    Transplantation; 1986 Dec; 42(6):702-3. PubMed ID: 3538557
    [No Abstract]   [Full Text] [Related]  

  • 12. The effects of donor specific transfusion and cyclosporine A on graft outcome.
    Haberal M; Oner Z; Aybasti N; Arslan G; Turan M; Bilgin N
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2269-70. PubMed ID: 3274506
    [No Abstract]   [Full Text] [Related]  

  • 13. Donor nonspecific blood transfusions before renal transplantation from haplo-mismatched living related donors.
    Shapira Z; Zamir R; Livni E; Yussim A; Shmueli D; Yehoshua H
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1834-5. PubMed ID: 2652596
    [No Abstract]   [Full Text] [Related]  

  • 14. The transfusion effect.
    Cecka JM
    Clin Transpl; 1987; ():287-301. PubMed ID: 3154420
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunosuppressive factors in patients after donor-specific transfusion with administration of cyclosporine.
    Yuzawa K; Otsuka M; Yu Y; Sharma N; Iwasaki H; Fukao K; Iwasaki Y
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1036-8. PubMed ID: 1824884
    [No Abstract]   [Full Text] [Related]  

  • 16. Mismatched living, related donor renal transplantation: a prospective, randomized study.
    Sommer BG; Ferguson RM
    Surgery; 1985 Aug; 98(2):267-74. PubMed ID: 3895539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the "NIMA effect" in renal transplantation. Collaborative Transplant Study.
    Opelz G
    Clin Transpl; 1990; ():63-7. PubMed ID: 2103176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Donor-specific T cell alloreactivity in relation to 1 haplotype-mismatched blood transfusion prior to living-donor renal transplantation.
    Bakran A; Taylor GM; Read I; Fergusson W; Johnson RW
    Transplant Proc; 1987 Feb; 19(1 Pt 1):748-9. PubMed ID: 2978929
    [No Abstract]   [Full Text] [Related]  

  • 19. Donor-specific blood transfusions versus cyclosporine--the DST story.
    Salvatierra O; Melzer J; Vincenti F; Amend WJ; Tomlanovich S; Potter D; Husing R; Garovoy M; Feduska NJ
    Transplant Proc; 1987 Feb; 19(1 Pt 1):160-6. PubMed ID: 3547813
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Donor source, number of transplants, age at transplant, and diabetes: risk factors in the cyclosporine era.
    Fryd DS; Kruse LV; Simmons RL; Sutherland DE; Payne WD; Najarian JS
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1655-6. PubMed ID: 2652542
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.